Scholarlink

<p>Pelvic MRI is essential for evaluating local and regional tumor extent in uterine cervical cancer (CC). Tumor microstructure captured by diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) markers may be closely linked to prognosis in CC.</p><p><b>Purpose</b> To explore whether primary tumor ADC markers predict survival&#xa0;in CC.</p><p><b>Material and methods</b> CC patients (<i>n</i> = 179) diagnosed during 2009–2020 with MRI-assessed primary maximum tumor<sub>size</sub> ≥ 2&#xa0;cm were included in this retrospective single-center study.&#xa0;Two radiologists read all MRIs independently, measuring mean tumor ADC values in manually drawn regions of interest (ROIs) and mean tumor ADC (tumor<sub>ADCmean</sub>) from five measurements for the two readers was used. ADC from ROIs in the myometrium (myometrium<sub>ADC</sub>), cervical stroma (cervix<sub>ADC</sub>), and bladder (bladder<sub>ADC</sub>) were used to calculate ADC ratios. ADC markers were&#xa0;explored&#xa0;in relation to the International Federation of Gynecology and Obstetrics (FIGO) (2018) stage, disease-specific survival (DSS), and recurrence/progression-free survival (RPFS).</p><p><b>Results</b> Inter-reader agreement for all ADC measurements was high (ICC:0.59–0.79). Low tumor<sub>ADCmean</sub> predicted advanced FIGO stage (<i>P</i> = 0.04) and reduced DSS (hazard ratio (HR): 0.96, <i>P</i> &lt; 0.001; AIC: 441). Myometrium<sub>ADC</sub>/tumor<sub>ADCmean</sub> yielded the best Cox regression fit (AIC = 430) among all tumor ADC markers. Patients with high myometrium<sub>ADC</sub>/tumor<sub>ADCmean</sub> had significantly reduced 5-year DSS for FIGO stage I, II, and III (<i>P</i> = 0.01, 0.004, and 0.02, respectively) and tended to the same for FIGO IV (<i>P</i> = 0.22).</p><p><b>Conclusion</b> Low tumor<sub>ADCmean</sub> predicted reduced&#xa0;DSS in CC. High myometrium<sub>ADC</sub>/tumor<sub>ADCmean</sub> was the strongest ADC predictor of poor DSS and a marker of high-risk phenotype independent of FIGO stage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月28日

查看全文
  • Njål Lura,
  • Kari S. Wagner-Larsen,
  • Stian Ryste,
  • Kristine Fasmer,
  • David Forsse,
  • Jone Trovik,
  • Mari K. Halle,
  • Bjørn I. Bertelsen,
  • Frank Riemer,
  • Øyvind Salvesen,
  • Kathrine Woie,
  • Camilla Krakstad,
  • Ingfrid S. Haldorsen

摘要

Pelvic MRI is essential for evaluating local and regional tumor extent in uterine cervical cancer (CC). Tumor microstructure captured by diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) markers may be closely linked to prognosis in CC.

Purpose To explore whether primary tumor ADC markers predict survival in CC.

Material and methods CC patients (n = 179) diagnosed during 2009–2020 with MRI-assessed primary maximum tumorsize ≥ 2 cm were included in this retrospective single-center study. Two radiologists read all MRIs independently, measuring mean tumor ADC values in manually drawn regions of interest (ROIs) and mean tumor ADC (tumorADCmean) from five measurements for the two readers was used. ADC from ROIs in the myometrium (myometriumADC), cervical stroma (cervixADC), and bladder (bladderADC) were used to calculate ADC ratios. ADC markers were explored in relation to the International Federation of Gynecology and Obstetrics (FIGO) (2018) stage, disease-specific survival (DSS), and recurrence/progression-free survival (RPFS).

Results Inter-reader agreement for all ADC measurements was high (ICC:0.59–0.79). Low tumorADCmean predicted advanced FIGO stage (P = 0.04) and reduced DSS (hazard ratio (HR): 0.96, P < 0.001; AIC: 441). MyometriumADC/tumorADCmean yielded the best Cox regression fit (AIC = 430) among all tumor ADC markers. Patients with high myometriumADC/tumorADCmean had significantly reduced 5-year DSS for FIGO stage I, II, and III (P = 0.01, 0.004, and 0.02, respectively) and tended to the same for FIGO IV (P = 0.22).

Conclusion Low tumorADCmean predicted reduced DSS in CC. High myometriumADC/tumorADCmean was the strongest ADC predictor of poor DSS and a marker of high-risk phenotype independent of FIGO stage.